Myopia and amblyopia
Conditions
Interventions
Optical Vision sky-n1201a, wavelength 650nm, power 0.37mw±0.02mw group 1:Optical Vision sky-n1201a, wavelength 650nm, power 0.37mw±0.02mw group 2
Optical vision sky-n1201a, wavelength 650nm, power 1.2mw group 1:Optical vision sky-n1201a, wavelength 650nm, power 1.2mw group 2
Skyn1201a, wavelength 650nm, power 0.6mw±0.2mw group 1:Skyn1201a, wavelength 650nm, power 0.6mw±0.2mw group 2
Optical Vision sky-n1201a, wavelength 650nm, power 0.37mw to 1.2mw±0.2mw group1:Optical Vision sky-n1201a, wavelength 650nm, power 0.37mw to 1.2mw±0.2mw group2
Sponsors
Tianjin Medical University Eye Hospital
Eligibility
Sex/Gender
All
Age
6 Years to 12 Years
Inclusion criteria
Inclusion criteria: (1) Age range from 6 to 12 years old, gender unlimited; (2) Patients with myopia in one or both eyes, binocular diopter difference =1.00DS; (3) Those who voluntarily gave up other treatments during the study; (4) Voluntarily use the product according to regulations, and can cooperate with the doctor's examination work; (5) Before the experiment, the guardian agrees and signs the informed consent.
Exclusion criteria
Exclusion criteria: (1) Congenital fundus defects (2) There are congenital eye diseases (3) Congenital glaucoma (4) Halo patients (5) Patients with a history of tourette syndrome (6) Patients with ADHD history (7) Patients with a history of epilepsy (8) Patients with psoriasis (9) Patients with ocular hypertension (10) Participate in other clinical studies within three months (11) Subjects deemed unsuitable by the researcher
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Axis change value; | — |
Secondary
| Measure | Time frame |
|---|---|
| Change in diopter; | — |
Countries
China
Contacts
Public ContactQian Xuehan
Outcome results
None listed